225 related articles for article (PubMed ID: 1922660)
41. The acetylcholinesterase inhibitor BW284c51 is a potent blocker of Torpedo nicotinic AchRs incorporated into the Xenopus oocyte membrane.
Olivera-Bravo S; Ivorra I; Morales A
Br J Pharmacol; 2005 Jan; 144(1):88-97. PubMed ID: 15644872
[TBL] [Abstract][Full Text] [Related]
42. Physostigmine, galanthamine and codeine act as 'noncompetitive nicotinic receptor agonists' on clonal rat pheochromocytoma cells.
Storch A; Schrattenholz A; Cooper JC; Abdel Ghani EM; Gutbrod O; Weber KH; Reinhardt S; Lobron C; Hermsen B; Soskiç V
Eur J Pharmacol; 1995 Aug; 290(3):207-19. PubMed ID: 7589215
[TBL] [Abstract][Full Text] [Related]
43. Is agonist self-inhibition at the nicotinic acetylcholine receptor a nonspecific action?
Forman SA; Firestone LL; Miller KW
Biochemistry; 1987 May; 26(10):2807-14. PubMed ID: 3038165
[TBL] [Abstract][Full Text] [Related]
44. Comparison of the actions of carbamate anticholinesterases on the nicotinic acetylcholine receptor.
Sherby SM; Eldefrawi AT; Albuquerque EX; Eldefrawi ME
Mol Pharmacol; 1985 Mar; 27(3):343-8. PubMed ID: 3974572
[TBL] [Abstract][Full Text] [Related]
45. Purification and characterization of an alpha-bungarotoxin receptor that forms a functional nicotinic channel.
Gotti C; Ogando AE; Hanke W; Schlue R; Moretti M; Clementi F
Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3258-62. PubMed ID: 2014250
[TBL] [Abstract][Full Text] [Related]
46. Differential binding of nicotine and alpha-bungarotoxin to residues 173-204 of the nicotinic acetylcholine receptor alpha 1 subunit.
Lentz TL
Biochemistry; 1995 Jan; 34(4):1316-22. PubMed ID: 7827079
[TBL] [Abstract][Full Text] [Related]
47. Histrionicotoxins: effects on binding of radioligands for sodium, potassium, and calcium channels in brain membranes.
Lovenberg T; Daly JW
Neurochem Res; 1986 Nov; 11(11):1609-21. PubMed ID: 2446155
[TBL] [Abstract][Full Text] [Related]
48. Effects of substance P on the binding of agonists to the nicotinic acetylcholine receptor of Torpedo electroplaque.
Min CK; Weiland GA
J Neurochem; 1993 Jun; 60(6):2238-46. PubMed ID: 7684070
[TBL] [Abstract][Full Text] [Related]
49. Functional nicotinic receptor expression in mesodermal cells transfected with MyoD cDNA.
Quik M; Odeh R; Philie J; Szyf M
Neuroscience; 1993 Dec; 57(3):787-95. PubMed ID: 8309537
[TBL] [Abstract][Full Text] [Related]
50. Neuronal-like features of TE671 cells: presence of a functional nicotinic cholinergic receptor.
Syapin PJ; Salvaterra PM; Engelhardt JK
Brain Res; 1982 Jan; 231(2):365-77. PubMed ID: 7055685
[TBL] [Abstract][Full Text] [Related]
51. Site specificity of agonist-induced opening and desensitization of the Torpedo californica nicotinic acetylcholine receptor.
Andreeva IE; Nirthanan S; Cohen JB; Pedersen SE
Biochemistry; 2006 Jan; 45(1):195-204. PubMed ID: 16388595
[TBL] [Abstract][Full Text] [Related]
52. Nicotinic pharmacology of anatoxin analogs. I. Side chain structure-activity relationships at peripheral agonist and noncompetitive antagonist sites.
Swanson KL; Aronstam RS; Wonnacott S; Rapoport H; Albuquerque EX
J Pharmacol Exp Ther; 1991 Oct; 259(1):377-86. PubMed ID: 1920124
[TBL] [Abstract][Full Text] [Related]
53. Interaction of the catecholamine release-inhibitory peptide catestatin (human chromogranin A(352-372)) with the chromaffin cell surface and Torpedo electroplax: implications for nicotinic cholinergic antagonism.
Taupenot L; Mahata SK; Mahata M; Parmer RJ; O'Connor DT
Regul Pept; 2000 Nov; 95(1-3):9-17. PubMed ID: 11062327
[TBL] [Abstract][Full Text] [Related]
54. Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists.
Jonnala RR; Buccafusco JJ
J Neurosci Res; 2001 Nov; 66(4):565-72. PubMed ID: 11746376
[TBL] [Abstract][Full Text] [Related]
55. Interactions of chlordecone (kepone) and mirex with the nicotinic acetylcholine receptor--ion channel complex.
Aronstam RS; Hong JS
Toxicol Lett; 1986 Mar; 30(3):247-51. PubMed ID: 2422792
[TBL] [Abstract][Full Text] [Related]
56. Nicotinic and muscarinic modulations of excitatory synaptic transmission in the rat prefrontal cortex in vitro.
Vidal C; Changeux JP
Neuroscience; 1993 Sep; 56(1):23-32. PubMed ID: 7901807
[TBL] [Abstract][Full Text] [Related]
57. Regulation of alpha-bungarotoxin sites in chromaffin cells in culture by nicotinic receptor ligands, K+, and cAMP.
Geertsen S; Afar R; Trifaró JM; Quik M
Mol Pharmacol; 1988 Oct; 34(4):549-56. PubMed ID: 2459593
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of the GABA receptor-gated chloride ion channel in brain by noncompetitive inhibitors of the nicotinic receptor-gated cation channel.
Schwartz RD; Mindlin MC
J Pharmacol Exp Ther; 1988 Mar; 244(3):963-70. PubMed ID: 2472481
[TBL] [Abstract][Full Text] [Related]
59. A role for the nicotinic alpha-bungarotoxin receptor in neurite outgrowth in PC12 cells.
Chan J; Quik M
Neuroscience; 1993 Sep; 56(2):441-51. PubMed ID: 8247271
[TBL] [Abstract][Full Text] [Related]
60. Interactions of d-tubocurarine with the nicotinic acetylcholine receptor/channel molecule.
Shaker N; Eldefrawi AT; Aguayo LG; Warnick JE; Albuquerque EX; Eldefrawi ME
J Pharmacol Exp Ther; 1982 Jan; 220(1):172-7. PubMed ID: 6273528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
